Allogeneic placental cell therapy utilizes cells derived from placental tissue for regenerative medicine and immunotherapy. These cells possess immunomodulatory and tissue-repair properties, making them ideal for treating conditions like autoimmune diseases, inflammatory disorders, and tissue damage. This approach offers a promising, scalable, and ethically sourced solution for advancing cell-based therapies.